التفاصيل البيبلوغرافية
| العنوان: |
Allogeneic hematopoietic cell transplantation; the current renaissance. |
| المؤلفون: |
Copelan, Edward A., Chojecki, Aleksander, Lazarus, Hillard M., Avalos, Belinda R. |
| المصدر: |
Blood Reviews; Mar2019, Vol. 34, p34-44, 11p |
| مستخلص: |
Abstract Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for many patients with malignant and nonmalignant hematologic disorders. Recent advances in selecting candidates and determining risk, procedure safety, utilization in older patients, use of alternative donors, and new or novel application of anti-cancer, immunosuppressive and antimicrobial agents have improved outcomes and expanded the role of HCT in hematologic disorders. Relapse remains the predominant cause of failure but enlightened use of new targeted and immunotherapeutic agents in combination with HCT promises to reduce relapse and further improve HCT outcomes. [ABSTRACT FROM AUTHOR] |
|
Copyright of Blood Reviews is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
